Driving Efficiencies Across the Life Sciences Value Chain with AI in Drug Development - with Nishtha Jain of Takeda
Release Date: 07/09/2024
The AI in Business Podcast
Consolidating hardware into fewer, more capable chips looks like an unambiguous win — until the complexity those separate components used to handle resurfaces in the software binding everything back together. In this episode, Sam Grove, Head of Software and Tools Business at MIPS, examines why hardware and software teams can't keep building in sequence, and why MIPS bet its roadmap on the open RISC-V standard instead of defending a proprietary instruction set, with host Yolandi de Weerdt. The conversation also covers how tools like MIPS Atlas Explorer help engineering teams see...
info_outlineThe AI in Business Podcast
Hospitals and clinics continue to face a central challenge: extensive cardiac testing still fails to deliver clear, consistent diagnostic answers, slowing decision‑making and creating downstream operational and financial strain. In this episode, Jim Hartman, Chief Commercial Officer at Cleerly, examines with host Marilie Fouché how AI‑driven coronary CTA analysis strengthens diagnostic certainty, streamlines workflows across radiology, cardiology, and the cath lab, and supports more defensible adoption decisions for clinical and operational leaders. The discussion highlights...
info_outlineThe AI in Business Podcast
Enterprise leaders face a growing gap between AI ambition and the fragmented data, legacy systems, and cultural friction that prevent pilots from becoming scalable value. In this episode, Julian Tang, Chief Operations Officer for the Innovation Office at BlackRock, examines how unified data foundations, modernized infrastructure, and transparent governance enable organizations to move from reactive experimentation to intentional, enterprise‑wide AI deployment, in conversation with host Matthew DeMello. He highlights the practical shifts required to reduce friction, build trust...
info_outlineThe AI in Business Podcast
Virtual cell models promise faster, cheaper early-stage drug discovery. However, the industry still lacks a shared way to judge which of these models can actually be trusted on a given problem. In this episode, Kristóf Szalay, CTO and Co-Founder of Turbine, and Gerold Csendes, Scientist at Turbine, set out what virtual cell models can and can't do today, in conversation with host Marilie Fouché. They cover why benchmarking remains fragmented across the field, how pharma teams build confidence in a model before trusting it with real R&D decisions, and how compressing the feedback...
info_outlineThe AI in Business Podcast
The rise of non‑invasive BCIs and the privacy, security, and human‑relevance questions they introduce is becoming a central concern as this technology moves toward practical use. In this episode, Paolo Ardoino, CEO at Tether, examines how lightweight on‑device models, silent‑speech inputs, and anonymized brain‑wave data can turn low‑bandwidth neural signals into real‑world actions, in conversation with host Daniel Faggella, Emerj CEO and Head of Research. The discussion focuses on emerging consumer use cases, long‑term cognitive augmentation, and the safeguards...
info_outlineThe AI in Business Podcast
Most retail AI pilots stall waiting on a years-long project to centralize and clean data before any agent can go live. In this episode, Chris Slovak, Global Field CTO at Unframe, makes the case for a different path: letting agents pull context directly from ERPs, CRMs, and point-of-sale systems as needed, in conversation with host Marilie Fouché. He walks through concrete results from that approach, including an inventory intelligence deployment that saved tens of thousands of dollars in time and data costs, and a deployment cycle that shrank from nine months to two weeks. This...
info_outlineThe AI in Business Podcast
Banks can process millions of transactions an hour, yet even routine steps in financial operations still require constant human judgment to hold together. In this episode, Ajay Swamy, Senior Executive Product Director for GenAI Products and Governance at JPMorganChase, and Founder of FundLens.ai, explores why data fragmentation and manual judgment make BFSI workflows hard to run consistently, and what it takes to make AI‑driven decisions explainable enough to trust at scale. The conversation covers evaluating AI for regulated environments, building oversight into agentic...
info_outlineThe AI in Business Podcast
Service leaders are increasingly asked to deploy AI agents without a clear sense of what these systems can safely handle today, or where to start. In this episode, Matt Kravitz, Head of Customer Transformation for Service Cloud at Salesforce, breaks down a three-level maturity model for AI service agents — answering questions, accessing account data, and taking action — and how to sequence adoption. The conversation also covers a channel-strategy framework for deciding which support requests to deflect, route to digital-assisted support, or escalate to a live conversation, and how a...
info_outlineThe AI in Business Podcast
The security landscape is shifting as AI accelerates existing vulnerabilities faster than most retail enterprises can adapt. In this episode, Mark Alvarado, CISO at Academy Sports + Outdoors, examines how AI amplifies gaps in identity management, data governance, and human behavior, joining Emerj’s Yolandi de Weerdt to clarify where leaders must focus before deploying AI‑enabled tools. He highlights the operational foundations that determine whether AI strengthens detection and response or simply magnifies unresolved weaknesses. Learn how leading brands and AI startups...
info_outlineThe AI in Business Podcast
A growing gap between device complexity and organizational knowledge is turning service reliability into an enterprise‑level risk for regulated industries. In this episode, Ryan Makely, Senior Director of CALID Service at Bruker Scientific, breaks down how fragmented documentation, rapid loss of expert judgment, and inconsistent field diagnoses undermine both operational performance and any future AI‑enabled support capability — in conversation with Emerj’s Marilie Fouché. Leaders will hear practical themes around building structured knowledge foundations, reducing...
info_outlineToday’s guest is Nishtha Jain, Head of Innovation and Digital Technology at Takeda Pharmaceuticals. Her role expands across Global R&D Quality in driving digital and data initiatives from concept to execution, leveraging emerging technologies and design principles. She joins us on the podcast today to talk about the efficiencies that AI can drive in the drug development space and how that benefits the entire value chain in life sciences. If you’ve enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!